%0 Editorial
%T Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence.
%A Kelly C
%A Barnett G
%A Iqbal MS
%J Clin Oncol (R Coll Radiol)
%V 0
%N 0
%D 2024 May 15
%M 38821724
%F 4.925
%R 10.1016/j.clon.2024.05.007